Latest Ascelia Pharma News & Updates

See the latest news and media coverage for Ascelia Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ascelia Pharma

Biotech company developing orphan oncology drugs

ascelia.com
Headquarters
Malmö, Sweden
Founded year
2000
Company type
Public company
Number of employees
10–50

Last updated

Latest news about Ascelia Pharma

In short: Ascelia Pharma advanced its Orviglance drug candidate, submitting an NDA to the FDA and securing a July 2026 decision date while raising capital.

Company announcements

  • Ascelia Pharma

    Ascelia Pharma holds annual general meeting

    Resolutions include adopting accounts, discharging board, re-electing members, approving LTI 2026 program, and rejecting share issue authorization.

  • Ascelia Pharma

    Ascelia Pharma conducts directed share issue

    Issues 6,666,666 shares at SEK 3 each to raise SEK 20 million, strengthening finances ahead of FDA decision.

  • Ascelia Pharma

    Ascelia Pharma publishes Annual Report 2025

    Orviglance NDA accepted by FDA with PDUFA date July 2026. Phase 3 SPARKLE met endpoints. Cash runway to Q4 2026.

  • Ascelia Pharma

    Ascelia Pharma invites to AGM

    The meeting occurs on 4 May 2026 in Malmö, covering board elections, remuneration, and incentive programs.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Ascelia Pharma

Track Ascelia Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ascelia Pharma competitors & trending companies

Browse news for competitors to Ascelia Pharma and other trending companies.